David Zarling

David Zarling
David A. Zarling, PhD, MBA
Occupation CEO, Colby Pharmaceutical Company

David A. Zarling, PhD, MBA is a co-founder, president and CEO of Colby Pharmaceutical Company and an oncology drug development scientist and entrepreneur.

Together with a team of scientists and executives from the University of Wisconsin–Madison, Stanford, UCSF as well as a number of biotechnology companies, Zarling formed Colby Pharmaceutical Company (CPC). The mission of CPC is to develop novel Reactive Oxygen Species (ROS)-targeting therapeutics for treatment and prevention of prostate cancer. The company received over $15 million in grants from National Cancer Institute, Department of Defense(DOD) and other institutions. CPC drug candidates showed significant pre-clinical efficacy in regression of prostate cancer and prevention of metastasis.[1][2]

Contents

Background

Before starting Colby Pharmaceutical Company, Zarling was a president and CEO of Pangene Corporation (PGC, Mt View, CA), a service company which provided drug and drug target development services in pharmaceuticals, genomics & cancer. Pangene was formed within and spun-out from SRI International, formerly Stanford Research Institute, Menlo Park, CA. Zarling co-founded PGC as a spin-out company from SRI International’s pharmaceutical drug development/genomics/cancer programs in the SRI Life Sciences Division, where he was a manager and program director. PGC sold its target bio-validation services to several pharmaceutical and biotechnology companies and achieved significant revenues. At SRI, and in collaboration with the SRI wholly owned for profit subsidiary, Sarnoff Corporation, Zarling helped organize, secure funding for and co-led a biotechnology platform based product development group. This group was responsible for significant new business and product development, including IP and product candidates, which were successfully out-licensed.

Prior to this, Zarling was employed at SRI International as a program director in the pharmaceutical drug development division, where he led a team which developed drug targets, oncology drug candidates and development of companion diagnostic product candidates. Some of these were developed for public international companies and others were out-licensed to public and private companies. At SRI, he also managed contract research for pharmaceutical and biotech companies and worked in drug development and consulting teams for domestic and international pharma and biotech companies. He led or was part of drug and associated companion diagnostic product development teams transitioning pre-clinical small molecule drugs into the clinic and he performed his doctoral work on small molecule anti-cancer drugs.

Zarling was also an Associate Adjunct Professor at the University of California San Francisco and has had several successful collaborations with clinical and pre-clinical investigators at major cancer and other research centers. He also has numerous peer-reviewed scientific publications, many issued US and Foreign patents and a deal sheet record for responsive and successful deals. David Zarling also has been a part of teams that successfully licensed technology to start-up companies, one of which subsequently achieved significant market capitalization . Dr. Zarling was a S. L. Brown Scholar and holds a BA with Honors in Biology, a MA in Molecular Biology/ Biological Sciences from Dartmouth College, a Ph.D. in Virology/Oncology, with emphasis on pharmaceutical drug development, from Baylor College of Medicine and an Executive MBA in Marketing/Finance from Pepperdine University.

See also

References

External links

Selected publications


Wikimedia Foundation. 2010.

Игры ⚽ Нужно решить контрольную?

Look at other dictionaries:

  • List of Dartmouth College alumni — This is an incomplete list, which may never be able to satisfy particular standards for completeness. You can help by expanding it with reliably sourced entries. The Dartmouth College class of 1920, posing in the Bema …   Wikipedia

  • The Bent Theatre — The Bent Theatre, formerly know as Whole World Theater Charlottesville, is an improvisational comedy troupe based in Charlottesville, Virginia. Founded by Jenn Horne, (formerly of The Whole World Theatre in Atlanta, Georgia) in 2004. The group… …   Wikipedia

  • Martin Chemnitz — (November 9, 1522 – April 8, 1586) was an eminent second generation Lutheran theologian, reformer, churchman, and confessor. In the Lutheran tradition he is known as Alter Martinus, the Second Martin : Si Martinus non fuisset, Martinus vix… …   Wikipedia

  • DNA — For a non technical introduction to the topic, see Introduction to genetics. For other uses, see DNA (disambiguation). The structure of the DNA double helix. The atoms in the structure are colour coded by element and the detailed structure of two …   Wikipedia

  • Les Chevaliers du futur — (Knights) est un film américain réalisé par Albert Pyun, sorti en 1993. Sommaire 1 Synopsis 2 Fiche technique 3 Distribution 4 Autour du film …   Wikipédia en Français

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”